Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells

IntroductionThe enhanced β-cell senescence that accompanies insulin resistance and aging contributes to cellular dysfunction and loss of transcriptional identity leading to type 2 diabetes (T2D). While senescence is among the 12 recognized hallmarks of aging, its relation to other hallmarks includin...

Full description

Bibliographic Details
Main Authors: Kanako Iwasaki, Benjamin Lalani, Jiho Kahng, Priscila Carapeto, Stephanie Sanjines, Francesko Hela, Cristian Abarca, Tadataka Tsuji, Justin Darcy, Andrzej Bartke, Yu-Hua Tseng, Rohit N. Kulkarni, Cristina Aguayo-Mazzucato
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1203534/full
_version_ 1797794240324960256
author Kanako Iwasaki
Kanako Iwasaki
Benjamin Lalani
Jiho Kahng
Priscila Carapeto
Stephanie Sanjines
Francesko Hela
Cristian Abarca
Tadataka Tsuji
Justin Darcy
Andrzej Bartke
Yu-Hua Tseng
Rohit N. Kulkarni
Cristina Aguayo-Mazzucato
author_facet Kanako Iwasaki
Kanako Iwasaki
Benjamin Lalani
Jiho Kahng
Priscila Carapeto
Stephanie Sanjines
Francesko Hela
Cristian Abarca
Tadataka Tsuji
Justin Darcy
Andrzej Bartke
Yu-Hua Tseng
Rohit N. Kulkarni
Cristina Aguayo-Mazzucato
author_sort Kanako Iwasaki
collection DOAJ
description IntroductionThe enhanced β-cell senescence that accompanies insulin resistance and aging contributes to cellular dysfunction and loss of transcriptional identity leading to type 2 diabetes (T2D). While senescence is among the 12 recognized hallmarks of aging, its relation to other hallmarks including altered nutrient sensing (insulin/IGF1 pathway) in β-cells is not fully understood. We previously reported that an increased expression of IGF1R in mouse and human β-cells is a marker of older β-cells; however, its contribution to age-related dysfunction and cellular senescence remains to be determined.MethodsIn this study, we explored the direct role of IGF1R in β-cell function and senescence using two independent mouse models with decreased IGF1/IGF1R signaling: a) Ames Dwarf mice (Dwarf +/+), which lack growth hormone and therefore have reduced circulating levels of IGF1, and b) inducible β-cell-specific IGF1R knockdown (βIgf1rKD) mice.ResultsCompared to Dwarf+/- mice, Dwarf+/+ mice had lower body and pancreas weight, lower circulating IGF1 and insulin levels, and lower IGF1R and p21Cip1 protein expression in β-cells, suggesting the suppression of senescence. Adult βIgf1rKD mice showed improved glucose clearance and glucose-induced insulin secretion, accompanied by decreased p21Cip1 protein expression in β-cells. RNA-Seq of islets isolated from these βIgf1rKD mice revealed the restoration of three signaling pathways known to be downregulated by aging: sulfide oxidation, autophagy, and mTOR signaling. Additionally, deletion of IGF1R in mouse β-cells increased transcription of genes important for maintaining β-cell identity and function, such as Mafa, Nkx6.1, and Kcnj11, while decreasing senescence-related genes, such as Cdkn2a, Il1b, and Serpine 1. Decreased senescence and improved insulin-secretory function of β-cells were also evident when the βIgf1rKD mice were fed a high-fat diet (HFD; 60% kcal from fat, for 5 weeks).DiscussionThese results suggest that IGF1R signaling plays a causal role in aging-induced β-cell dysfunction. Our data also demonstrate a relationship between decreased IGF1R signaling and suppressed cellular senescence in pancreatic β-cells. Future studies can further our understanding of the interaction between senescence and aging, developing interventions that restore β-cell function and identity, therefore preventing the progression to T2D.
first_indexed 2024-03-13T02:59:54Z
format Article
id doaj.art-a9c12083d3e244c1aa69f5f508cb46b4
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-13T02:59:54Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-a9c12083d3e244c1aa69f5f508cb46b42023-06-27T15:28:37ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-06-011410.3389/fendo.2023.12035341203534Decreased IGF1R attenuates senescence and improves function in pancreatic β-cellsKanako Iwasaki0Kanako Iwasaki1Benjamin Lalani2Jiho Kahng3Priscila Carapeto4Stephanie Sanjines5Francesko Hela6Cristian Abarca7Tadataka Tsuji8Justin Darcy9Andrzej Bartke10Yu-Hua Tseng11Rohit N. Kulkarni12Cristina Aguayo-Mazzucato13Section on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesMedical Research Institute, Kitano Hospital, Osaka, JapanSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Integrative Physiology and Metabolism, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Integrative Physiology and Metabolism, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesDepartment of Internal Medicine, Division of Geriatrics Research, Department of Medicine, Southern Illinois University School of Medicine, Springfield, IL, United StatesSection on Integrative Physiology and Metabolism, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesSection on Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, United StatesIntroductionThe enhanced β-cell senescence that accompanies insulin resistance and aging contributes to cellular dysfunction and loss of transcriptional identity leading to type 2 diabetes (T2D). While senescence is among the 12 recognized hallmarks of aging, its relation to other hallmarks including altered nutrient sensing (insulin/IGF1 pathway) in β-cells is not fully understood. We previously reported that an increased expression of IGF1R in mouse and human β-cells is a marker of older β-cells; however, its contribution to age-related dysfunction and cellular senescence remains to be determined.MethodsIn this study, we explored the direct role of IGF1R in β-cell function and senescence using two independent mouse models with decreased IGF1/IGF1R signaling: a) Ames Dwarf mice (Dwarf +/+), which lack growth hormone and therefore have reduced circulating levels of IGF1, and b) inducible β-cell-specific IGF1R knockdown (βIgf1rKD) mice.ResultsCompared to Dwarf+/- mice, Dwarf+/+ mice had lower body and pancreas weight, lower circulating IGF1 and insulin levels, and lower IGF1R and p21Cip1 protein expression in β-cells, suggesting the suppression of senescence. Adult βIgf1rKD mice showed improved glucose clearance and glucose-induced insulin secretion, accompanied by decreased p21Cip1 protein expression in β-cells. RNA-Seq of islets isolated from these βIgf1rKD mice revealed the restoration of three signaling pathways known to be downregulated by aging: sulfide oxidation, autophagy, and mTOR signaling. Additionally, deletion of IGF1R in mouse β-cells increased transcription of genes important for maintaining β-cell identity and function, such as Mafa, Nkx6.1, and Kcnj11, while decreasing senescence-related genes, such as Cdkn2a, Il1b, and Serpine 1. Decreased senescence and improved insulin-secretory function of β-cells were also evident when the βIgf1rKD mice were fed a high-fat diet (HFD; 60% kcal from fat, for 5 weeks).DiscussionThese results suggest that IGF1R signaling plays a causal role in aging-induced β-cell dysfunction. Our data also demonstrate a relationship between decreased IGF1R signaling and suppressed cellular senescence in pancreatic β-cells. Future studies can further our understanding of the interaction between senescence and aging, developing interventions that restore β-cell function and identity, therefore preventing the progression to T2D.https://www.frontiersin.org/articles/10.3389/fendo.2023.1203534/fullsenescenceSASPIGF-1insulinDwarfdiabetes mellitus
spellingShingle Kanako Iwasaki
Kanako Iwasaki
Benjamin Lalani
Jiho Kahng
Priscila Carapeto
Stephanie Sanjines
Francesko Hela
Cristian Abarca
Tadataka Tsuji
Justin Darcy
Andrzej Bartke
Yu-Hua Tseng
Rohit N. Kulkarni
Cristina Aguayo-Mazzucato
Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
Frontiers in Endocrinology
senescence
SASP
IGF-1
insulin
Dwarf
diabetes mellitus
title Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
title_full Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
title_fullStr Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
title_full_unstemmed Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
title_short Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells
title_sort decreased igf1r attenuates senescence and improves function in pancreatic β cells
topic senescence
SASP
IGF-1
insulin
Dwarf
diabetes mellitus
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1203534/full
work_keys_str_mv AT kanakoiwasaki decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT kanakoiwasaki decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT benjaminlalani decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT jihokahng decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT priscilacarapeto decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT stephaniesanjines decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT franceskohela decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT cristianabarca decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT tadatakatsuji decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT justindarcy decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT andrzejbartke decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT yuhuatseng decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT rohitnkulkarni decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells
AT cristinaaguayomazzucato decreasedigf1rattenuatessenescenceandimprovesfunctioninpancreaticbcells